Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Tanaka

Showing results (231-240 of 267) with videos related to

Pageof 27
Sort By:
American Journal of Hematology|October 7, 2017
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adultsYasuyuki Arai, Tadakazu Kondo, Akio Shigematsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2019
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell TransplantationAyumi Fujimoto, Nobuhiro Hiramoto, Satoshi Yamasaki, et al.
Bone Marrow Transplantation|December 15, 2018
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphomaMakoto Yoshimitsu, Atae Utsunomiya, Shigeo Fuji, et al.
Blood Cancer Journal|September 25, 2021
Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysisShuhei Kurosawa, Shohei Mizuno, Yasuyuki Arai, et al.
Blood|May 8, 2010
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanMasako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, et al.
Blood Advances|June 23, 2022
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decadesSatoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, et al.
European Journal of Haematology|January 21, 2025
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based RegimenAkihito Shinohara, Michiho Shindo, Nobuaki Nakano, et al.
Hematological Oncology|April 8, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantationYutaka Shimazu, Makoto Murata, Takeshi Kondo, et al.
Bone Marrow Transplantation|May 16, 2021
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patientsYoshimitsu Shimomura, Masahiko Hara, Takaaki Konuma, et al.
International Journal of Clinical Oncology|July 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapseHiroshi Yasui, Masayuki Kobayashi, Kota Sato, et al.
Pageof 27

Showing results (231-240 of 267) with videos related to

Sort By:
Pageof 27
American Journal of Hematology|October 7, 2017
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adultsYasuyuki Arai, Tadakazu Kondo, Akio Shigematsu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2019
Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell TransplantationAyumi Fujimoto, Nobuhiro Hiramoto, Satoshi Yamasaki, et al.
Bone Marrow Transplantation|December 15, 2018
A retrospective analysis of haplo-identical HLA-mismatch hematopoietic transplantation without posttransplantation cyclophosphamide for GVHD prophylaxis in patients with adult T-cell leukemia-lymphomaMakoto Yoshimitsu, Atae Utsunomiya, Shigeo Fuji, et al.
Blood Cancer Journal|September 25, 2021
Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysisShuhei Kurosawa, Shohei Mizuno, Yasuyuki Arai, et al.
Blood|May 8, 2010
Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in JapanMasako Iwanaga, Toshiki Watanabe, Atae Utsunomiya, et al.
Blood Advances|June 23, 2022
Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decadesSatoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, et al.
European Journal of Haematology|January 21, 2025
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based RegimenAkihito Shinohara, Michiho Shindo, Nobuaki Nakano, et al.
Hematological Oncology|April 8, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantationYutaka Shimazu, Makoto Murata, Takeshi Kondo, et al.
Bone Marrow Transplantation|May 16, 2021
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patientsYoshimitsu Shimomura, Masahiko Hara, Takaaki Konuma, et al.
International Journal of Clinical Oncology|July 14, 2021
Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapseHiroshi Yasui, Masayuki Kobayashi, Kota Sato, et al.
Pageof 27